The MHRA oversees the approval process for new medications, including those used in cancer treatment. This involves rigorous assessment of clinical trial data to ensure that the benefits of a new medicine outweigh any potential risks. The agency also monitors adverse effects once a drug is on the market to ensure ongoing safety.
